Carmel Capital Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Carmel Capital Partners's LLY Position: Q3 2026 in Review
Carmel Capital Partners increased its Eli Lilly (LLY) stake by 0.31% in Q3 2026, buying an estimated $2.36K and bringing the position to 649 shares worth $751K. The position accounts for 0.27% of the portfolio, ranked #70.
Carmel Capital Partners first reported a position in LLY in Q4 2022 and has held it in 16 quarters since. The position peaked at $776K in Q2 2026. 4,599 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Carmel Capital Partners held 649 shares of Eli Lilly worth $751K as of Q3 2026.
- Carmel Capital Partners bought 2 Eli Lilly shares in Q3 2026, an estimated $2.36K.
- Eli Lilly made up 0.27% of Carmel Capital Partners's portfolio in Q3 2026, its #70 holding.
- Carmel Capital Partners first reported a position in Eli Lilly in Q4 2022 and has held it in 16 quarters since.
- Carmel Capital Partners's Eli Lilly position peaked at $776K in Q2 2026.
- 4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Carmel Capital Partners's 13F filing for Q3 2026, filed 3 Nov 2026.